Jodi Ann Wagner, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 451 Junction Road, Madison, WI 53717 Phone: 608-265-7601 Fax: 608-265-7581 |
Hannah Marie Copp, Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 202 S Park St, Madison, WI 53715 Phone: 608-417-6326 |
Anastasia Doherty, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 451 Junction Rd, Madison, WI 53717 Phone: 608-265-7042 |
Jessica M Vaughan, DNP, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 1313 Fish Hatchery Rd, Madison, WI 53715 Phone: 608-252-8000 Fax: 608-283-7354 |
Lisa A Wachholz, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 451 Junction Rd, Madison, WI 53717 Phone: 608-263-0150 Fax: 608-833-6932 |
News Archive
Post-traumatic stress disorder is often thought of as a symptom of warfare, major catastrophes and assault. It's rarely considered in patients who survive a critical illness and stay in the intensive care unit (ICU).
Doses of radiation from commonly performed computed tomography (CT) scans vary widely, appear higher than generally believed and may contribute to an estimated tens of thousands of future cancer cases, according to two reports in the December 14/28 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Today, the American Society of Anesthesiologists announced strong opposition to the surprise medical bill introduced Tuesday, July 9 and passed today by the House Energy and Commerce Subcommittee on Health, the "Pallone-Walden" bill, or H.R. 3630 the "No Surprises Act."
African-American men are more than twice as likely to die of prostate cancer compared to Caucasian men. World renowned robotic prostate surgeon, Dr. David Samadi, encourages them to have a complete family history of prostate cancer as part of their prevention plan.
Idera Pharmaceuticals, Inc. today announced that it will be presenting data from preclinical studies of its Toll-like receptor (TLR) inhibitor, IMO-8400, in models of systemic lupus erythematosus (SLE) and psoriasis, which suggest that IMO-8400 may be useful for the treatment of both indications.
› Verified 8 days ago